University of Cincinnati Biologists Achieve World-First Visualization of Key Cell Protein

Structural biologists at the University of Cincinnati have achieved a groundbreaking world-first, successfully visualizing a pivotal cellular protein as part of newly published research from the College of Medicine. This monumental achievement by the Seegar Lab marks the first time scientists have been able to distinctly observe the structure of iRhom1, a crucial regulator protein, precisely bound to the ADAM17 enzyme. This unprecedented visualization was made possible through the sophisticated capabilities of cryogenic electron microscopy (cryo-EM). The cutting-edge cryo-EM technology, housed within UC's state-of-the-art Center for Advanced Structural Biology research facility, proved instrumental in this discovery. Cryo-EM allows researchers to image biological molecules at atomic resolution, providing intricate details of their three-dimensional structures. This technique has revolutionized structural biology by enabling scientists to study proteins and other biomolecules in their near-native states, offering insights that were previously unattainable with conventional methods. The significance of visualizing the iRhom1-ADAM17 complex cannot be overstated. ADAM17 is an enzyme known as a "sheddase," playing a critical role in cleaving and releasing various proteins from the cell surface, including growth factors, cytokines, and adhesion molecules. Its activity is implicated in a wide array of physiological and pathological processes, such as inflammation, cancer progression, and neurodegenerative diseases. Understanding how iRhom1 regulates ADAM17's activity is therefore fundamental to comprehending these complex biological pathways. This detailed structural insight provides a molecular blueprint for how iRhom1 controls ADAM17. By revealing the precise interaction points and conformational changes that occur when these two proteins bind, the research paves the way for a deeper understanding of cellular signaling. Such knowledge is invaluable for the development of highly targeted therapeutic strategies. For instance, drugs could be designed to modulate the iRhom1-ADAM17 interaction, potentially offering new treatments for conditions where ADAM17 activity is dysregulated. The pioneering work from the University of Cincinnati not only highlights the institution's leadership in advanced structural biology but also represents a significant leap forward for the global scientific community. This visualization provides a critical foundation for future research into the intricate mechanisms governing cell function and disease. It underscores the power of advanced imaging techniques in unraveling the mysteries of life at its most fundamental level, promising new avenues for medical breakthroughs.